Vargatef®

nintedanib

About Vargatef®

Combination therapy with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first-line chemotherapy.

 

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

Non-small cell lung cancer (NSCLC)

Brand Names

Vargatef®

Active ingredients

nintedanib